Sopharma AD-Sofia (FRA:3JR) Cyclically Adjusted PB Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3JR Sopharma AD-Sofia FRA:3JR
58 GF Score
Price €2.11
GF Value €2.95
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sopharma AD-Sofia  (FRA:3JR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sopharma AD-Sofia Cyclically Adjusted PB Ratio Related Terms


Sopharma AD-Sofia Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia Cyclically Adjusted PB Ratio Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 1.96 2.34 2.25 1.07

Sopharma AD-Sofia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.71 1.03 1.07 0.67 0.00

FRA:3JR vs MCK, COR, CAH: Cyclically Adjusted PB Ratio Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Cyclically Adjusted PB Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Cyclically Adjusted PB Ratio falls into.


FRA:3JR
58GF Score
Sopharma AD-Sofia FRA:3JR
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sopharma AD-Sofia's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Sopharma AD-Sofia's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.016/333.9520*333.9520
=1.016

Current CPI (Jun. 2026) = 333.9520.

Sopharma AD-Sofia Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.667 241.018 2.310
201609 1.690 241.428 2.338
201612 1.825 241.432 2.524
201703 1.873 243.801 2.566
201706 1.870 244.955 2.549
201709 1.899 246.819 2.569
201712 1.904 246.524 2.579
201803 1.948 249.554 2.607
201806 1.921 251.989 2.546
201809 1.925 252.439 2.547
201812 1.924 251.233 2.557
201903 1.998 254.202 2.625
201906 2.022 256.143 2.636
201909 2.070 256.759 2.692
201912 2.255 256.974 2.930
202006 2.296 257.797 2.974
202009 2.274 260.280 2.918
202012 2.241 260.474 2.873
202103 0.000 264.877 0.000
202106 2.366 271.696 2.908
202109 2.472 274.310 3.009
202112 2.707 278.802 3.242
202203 2.789 287.504 3.240
202206 2.884 296.311 3.250
202209 2.979 296.808 3.352
202212 2.943 296.797 3.311
202303 3.091 301.836 3.420
202306 2.927 305.109 3.204
202309 3.005 307.789 3.260
202312 2.374 306.746 2.585
202403 2.561 312.332 2.738
202406 2.465 314.175 2.620
202409 2.509 315.301 2.657
202412 2.514 315.605 2.660
202503 2.641 319.799 2.758
202506 2.670 322.561 2.764
202509 0.935 324.800 0.961
202512 0.918 324.054 0.946
202603 0.989 330.213 1.000
202606 1.016 333.952 1.016

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of €2.11 is trading 28.5% below its estimated GF Value™ of €2.95.

Key valuation signals for FRA:3JR:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €2.95 vs. price of €2.11 (28.5% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges SPH:PolandSFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
58GF Score

Get the complete analysis for FRA:3JR

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.11
Price
€2.95
GF Value